Swift Deep TMS™ is the newest TMS treatment protocol. Tested at Stanford University it is a more accessible form of TMS treatment using our industry leading BrainsWay technology. Recently BrainsWay completed their own research which has been FDA approved for treating major depressive disorder (MDD). This treatment included completing a total of 30 Theta Burst Stimulation (TBS) sessions over a six-day period. The BrainsWay study found the efficacy of this accelerated protocol was almost identical to the standard four-to-six-week course.

Swift Deep TMS™ is a more intense treatment for depression that increases the number of treatment sessions per day, however, treats the depression in just two weeks vs. the standard six-week protocol. This includes ten treatments a day for six days over one-week followed by two day a week for two weeks. Like Deep TMS™, Swift Deep TMS™ is non-invasive and includes electromagnetic pulses to the brain. This new protocol medium time to remission is 21 days vs. Deep TMS, which is 28 days.